MedPath

Bismuth Subnitrate

Generic Name
Bismuth Subnitrate
Drug Type
Small Molecule
Chemical Formula
Bi5H9N4O22
CAS Number
1304-85-4
Unique Ingredient Identifier
H19J064BA5

Overview

Bismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent . The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA.

Indication

主要用于消化性溃疡、腹泻、肠炎等。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
ROTER TAB
N/A
N/A
N/A
10/23/2001
SPAGASTROL TAB
N/A
N/A
N/A
3/5/1987

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ROTER TABLETS
roter pharmaceutische fabriek
00173797
Tablet - Oral
350 MG
12/31/1952
BISMUTUM SUBNITRICUM-INJEEL LIQ (12D,30D,200D/1.1ML)
02062496
Liquid - Oral
12 D / 1.1 ML
12/31/1994
BISMUTHUM SUBNITRICUM
dolisos canada inc.
02234352
Liquid ,  Globules ,  Granules - Oral
6 X
1/5/1998
BISMUTUM SUBNITRICUM-INJEEL FORTE LIQ (6D,12D,30D,200D/1.1ML)
02066262
Liquid - Oral
6 D / 1.1 ML
12/31/1994
HEMORRO-DOL SUP
produits francais labs inc.
00540919
Suppository - Rectal
37.8 MG / SUP
12/31/1981
HEMORRO-DOL ONT
produits francais labs inc.
00540900
Ointment - Rectal
1.5 %
12/31/1981

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.